Home Newsfeeds Credit Suisse Upgrades AltaGas to Outperform

Credit Suisse Upgrades AltaGas to Outperform

Credit Suisse analyst Andrew Kuske upgrades AltaGas (TSX:ALA) from Neutral to Outperform.

byBenzinga Newsdesk

October 25, 2022

1 minute read

Credit Suisse analyst Andrew Kuske upgrades AltaGas (TSX:ALA) from Neutral to Outperform.

Investigating Automatic Data Processing’s Standing In Professional Services Industry Compared To Competitors

By Benzinga Insights

January 4, 12:00 PM

In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for…

ADP

Here’s How Much $100 Invested In Biogen 20 Years Ago Would Be Worth Today

By Benzinga Insights

September 28, 3:46 PM

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 2.9% on an annualized basis producing an average annual return of 10.93%. Currently, Biogen has a market capitalization of $39.91 billion.

BIIB

Jefferies Upgrades Harmony Biosciences to Buy, Raises Price Target to $61

By Benzinga Newsdesk

October 14, 6:25 AM

Jefferies analyst Chris Howerton upgrades Harmony Biosciences (NASDAQ:HRMY) from Hold to Buy and raises the price target from $57 to $61.

HRMY

Global Central Banks Announce Coordinated Action As Banking Crisis Deepens: What Investors Should Know Ahead Of Trading Week

By Shanthi Rexaline

March 19, 6:15 PM

As the turmoil in the banking system claims more scalps, central banks across the globe announced a coordinated action, underlining the gravity of the problem at hand.

Credit Suisse Upgrades AltaGas to Outperform

Related Posts

Investigating Automatic Data Processing’s Standing In Professional Services Industry Compared To Competitors

Here’s How Much $100 Invested In Biogen 20 Years Ago Would Be Worth Today

Jefferies Upgrades Harmony Biosciences to Buy, Raises Price Target to $61

Global Central Banks Announce Coordinated Action As Banking Crisis Deepens: What Investors Should Know Ahead Of Trading Week